Skip Nav Destination
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
Issue Archive
June 15 2005
Table of Contents
INSIDE BLOOD
REVIEW IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
Clinical Trials & Observations
Peter McLaughlin,Elihu Estey,Armand Glassman,Jorge Romaguera,Felipe Samaniego,Ana Ayala,Kimberly Hayes,Anne Marie Maddox,H. Alejandro Preti,Fredrick B. Hagemeister
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab
Clinical Trials & Observations
John M. Bennett,Mark S. Kaminski,John P. Leonard,Julie M. Vose,Andrew D. Zelenetz,Susan J. Knox,Sandra Horning,Oliver W. Press,John A. Radford,Stewart M. Kroll,Robert L. Capizzi
GENE THERAPY
HEMATOPOIESIS
An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray
Benjamin L. Ebert,Michele M. Lee,Jennifer L. Pretz,Aravind Subramanian,Raymond Mak,Todd R. Golub,Colin A. Sieff
Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia
Johan Flygare,Thomas Kiefer,Koichi Miyake,Taiju Utsugisawa,Isao Hamaguchi,Lydie Da Costa,Johan Richter,Edward J. Davey,Hans Matsson,Niklas Dahl,Maciej Wiznerowicz,Didier Trono,Stefan Karlsson
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
High level of endothelial cell-specific gene expression by a combination of the 5′ flanking region and the 5′ half of the first intron of the VE-cadherin gene
Hiroshi Hisatsune,Kazuyoshi Matsumura,Minetaro Ogawa,Akiyoshi Uemura,Nobuyuki Kondo,Jun K. Yamashita,Hideto Katsuta,Satomi Nishikawa,Tsutomu Chiba,Shin-Ichi Nishikawa
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation
Paula G. Heller,Ana C. Glembotsky,Manish J. Gandhi,Carrie L. Cummings,Carlos J. Pirola,Rosana F. Marta,Laura I. Kornblihtt,Jonathan G. Drachman,Felisa C. Molinas
IMMUNOBIOLOGY
NEOPLASIA
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells
Kuichun Zhu,Elvira Gerbino,Darrin M. Beaupre,Paul A. Mackley,Carlos Muro-Cacho,Craig Beam,Andrew D. Hamilton,Mathias G. Lichtenheld,William G. Kerr,William Dalton,Melissa Alsina,Saïd M. Sebti
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
Ludovic Deriano,Olivier Guipaud,Hélène Merle-Béral,Jacques-Louis Binet,Michelle Ricoul,Gaby Potocki-Veronese,Vincent Favaudon,Zofia Maciorowski,Catherine Muller,Bernard Salles,Laure Sabatier,Jozo Delic
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome
Clinical Trials & Observations
Marco Ladetto,Sonia Vallet,Andreas Trojan,Maria Dell'Aquila,Luigia Monitillo,Rosalba Rosato,Loredana Santo,Daniela Drandi,Alessandra Bertola,Patrizia Falco,Federica Cavallo,Irene Ricca,Federica De Marco,Barbara Mantoan,Beata Bode-Lesniewska,Gloria Pagliano,Roberto Francese,Alberto Rocci,Monica Astolfi,Mara Compagno,Sara Mariani,Laura Godio,Lydia Marino,Marina Ruggeri,Paola Omedè,Antonio Palumbo,Mario Boccadoro
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
Clinical Trials & Observations
Pawel Grabowski,Magnus Hultdin,Karin Karlsson,Gerard Tobin,Anna Åleskog,Ulf Thunberg,Anna Laurell,Christer Sundström,Richard Rosenquist,Göran Roos
Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
Eva Mikaelsson,Amir Hossein Danesh-Manesh,Alfred Lüppert,Mahmood Jeddi-Tehrani,Mohammad-Reza Rezvany,Ramazan Ali Sharifian,Reza Safaie,Azam Roohi,Anders Österborg,Fazel Shokri,Håkan Mellstedt,Hodjattallah Rabbani
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma
Clinical Trials & Observations
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
Clinical Trials & Observations
Katharine C. Hsu,Carolyn A. Keever-Taylor,Andrew Wilton,Clara Pinto,Glenn Heller,Knarik Arkun,Richard J. O'Reilly,Mary M. Horowitz,Bo Dupont
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals